Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY

dihydroergotamine mesylate
$32.7695per ML

Strength

4 mg/mL

Manufacturer

Oceanside Pharmaceuticals

NDC

68682035710

Classification

Generic

Dosage Form

SPRAY

Route

NASAL

Last Updated

9/17/2025

Active Ingredients

DIHYDROERGOTAMINE MESYLATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020148

On Market Since

3/18/2013

Pharmacological Classes

Ergotamine Derivative
Ergotamines

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-11.5%

3Y

-70.6%

5Y

-72.5%

All

-80.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MIGERGOT SUPPOSITORY
Generic
00713016612•Cosette Pharmaceuticals, Inc.
$23.7433
per EA
DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY
Generic
24201046308•Hikma Pharmaceuticals USA Inc.
$35.4287
per ML
DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY
Generic
69097050327•Cipla USA Inc.
$35.4287
per ML
DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY
Generic
72888009619•Advagen Pharma Ltd.
$35.4287
per ML
DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY
Generic
73352009619•Trifluent Pharma LLC
$35.4287
per ML
DIHYDROERGOTAMINE 1 MG/ML AMP
Generic
81284041105•Provepharm Inc.
$52.6420
per ML
DIHYDROERGOTAMINE 1 MG/ML AMP
Generic
00143927310•Hikma Pharmaceuticals USA Inc.
$68.0082
per ML
DIHYDROERGOTAMINE 1 MG/ML AMP
Generic
81284041110•Provepharm Inc.
$68.0082
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy